| Katie Elaine Malone, DNP, AGCNS-BC | |
|
1325 Pennsylvania Ave Ste 500, Fort Worth, TX 76104-2130 | |
| (817) 250-2000 | |
| Not Available |
| Full Name | Katie Elaine Malone |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 1325 Pennsylvania Ave Ste 500, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144843103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | AP146109 (Texas) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | AP146109 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Health Physicians Group | 4385535954 | 1182 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ's to discuss FDA directives on immunogenicity introduced in 2008.
Bill Gates, Co-Chair and Trustee of the Bill & Melinda Gates Foundation, will provide a keynote address on the opportunity of mobile technologies to improve health outcomes in the developing world at the 2010 mHealth Summit, the summit organizers announced today. The summit, organized by the Foundation for the National Institutes of Health in partnership with the National Institutes of Health (NIH) and the mHealth Alliance, will be held November 8-10 in Washington, DC.
› Verified 2 days ago
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ's to discuss FDA directives on immunogenicity introduced in 2008.
Bill Gates, Co-Chair and Trustee of the Bill & Melinda Gates Foundation, will provide a keynote address on the opportunity of mobile technologies to improve health outcomes in the developing world at the 2010 mHealth Summit, the summit organizers announced today. The summit, organized by the Foundation for the National Institutes of Health in partnership with the National Institutes of Health (NIH) and the mHealth Alliance, will be held November 8-10 in Washington, DC.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie Elaine Malone, DNP, AGCNS-BC 580 S Point Ct, Aledo, TX 76008-4229 Ph: (817) 999-2301 | Katie Elaine Malone, DNP, AGCNS-BC 1325 Pennsylvania Ave Ste 500, Fort Worth, TX 76104-2130 Ph: (817) 250-2000 |
News Archive
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.
A biologist at Washington University in St. Louis is giving the VIP treatment to laboratory mice in hopes of unraveling more clues about our biological clock.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
This May, Joao Pedras-Vasconcelos, Visiting Associate, Therapeutic Proteins CBER from FDA will meet with European industry experts at Pharma IQ's to discuss FDA directives on immunogenicity introduced in 2008.
Bill Gates, Co-Chair and Trustee of the Bill & Melinda Gates Foundation, will provide a keynote address on the opportunity of mobile technologies to improve health outcomes in the developing world at the 2010 mHealth Summit, the summit organizers announced today. The summit, organized by the Foundation for the National Institutes of Health in partnership with the National Institutes of Health (NIH) and the mHealth Alliance, will be held November 8-10 in Washington, DC.
› Verified 2 days ago
Mrs. Amy Michelle Medalie, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4405 River Oaks Blvd, Fort Worth, TX 76114 Phone: 817-624-1770 Fax: 817-625-1287 | |
Valerie Elise Ward, RN, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2755 Miller Ave, Fort Worth, TX 76105 Phone: 817-534-7110 Fax: 817-413-0521 | |
Maria Sybil Gagliano, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6000 Bryant Irvin Rd, Fort Worth, TX 76132 Phone: 866-389-2727 | |
Kristi E Tucker, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 | |
Lacy Pitchford, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1263 W Rosedale St Ste 200, Fort Worth, TX 76104 Phone: 817-336-4896 Fax: 817-332-2805 | |
Mary Agnes Johnson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave, Fort Worth, TX 76104 Phone: 817-922-7070 | |
Susan Akberzie, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1401 W Pulaski St, Fort Worth, TX 76104 Phone: 682-885-8012 Fax: 682-885-8014 |